Beverages - Wineries & Distilleries
Compare Stocks
4 / 10Stock Comparison
STZ vs DEO vs BUD vs TAP
Revenue, margins, valuation, and 5-year total return — side by side.
Beverages - Wineries & Distilleries
Beverages - Alcoholic
Beverages - Alcoholic
STZ vs DEO vs BUD vs TAP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Beverages - Wineries & Distilleries | Beverages - Wineries & Distilleries | Beverages - Alcoholic | Beverages - Alcoholic |
| Market Cap | $26.05B | $46.38B | $138.11B | $8.10B |
| Revenue (TTM) | $9.38B | $37.37B | $119.82B | $11.19B |
| Net Income (TTM) | $1.11B | $5.49B | $12.57B | $-2.11B |
| Gross Margin | 52.0% | 60.0% | 55.2% | 37.8% |
| Operating Margin | 34.5% | 27.9% | 31.7% | -20.3% |
| Forward P/E | 12.7x | 17.8x | 18.8x | 9.2x |
| Total Debt | $12.11B | $24.40B | $72.17B | $6.30B |
| Cash & Equiv. | $68M | $2.20B | $11.17B | $897M |
STZ vs DEO vs BUD vs TAP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Constellation Brand… (STZ) | 100 | 87.0 | -13.0% |
| Diageo plc (DEO) | 100 | 59.3 | -40.7% |
| Anheuser-Busch InBe… (BUD) | 100 | 171.2 | +71.2% |
| Molson Coors Bevera… (TAP) | 100 | 113.6 | +13.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: STZ vs DEO vs BUD vs TAP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
STZ is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 2.5%, EPS growth -104.8%, 3Y rev CAGR 5.0%
- 12.6% 10Y total return vs BUD's -24.5%
- Lower volatility, beta 0.26, current ratio 0.92x
- Beta 0.26, yield 2.7%, current ratio 0.92x
DEO carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 12 yrs, beta 0.37, yield 4.9%
- 14.7% margin vs TAP's -18.9%
- 4.9% yield, 12-year raise streak, vs TAP's 4.5%
- 14.7% ROA vs TAP's -8.9%, ROIC 9.6% vs -10.1%
BUD is the clearest fit if your priority is momentum.
- +24.5% vs DEO's -25.1%
TAP is the clearest fit if your priority is value.
- Lower P/E (9.2x vs 18.8x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.5% revenue growth vs TAP's -4.2% | |
| Value | Lower P/E (9.2x vs 18.8x) | |
| Quality / Margins | 14.7% margin vs TAP's -18.9% | |
| Stability / Safety | Beta 0.26 vs DEO's 0.37, lower leverage | |
| Dividends | 4.9% yield, 12-year raise streak, vs TAP's 4.5% | |
| Momentum (1Y) | +24.5% vs DEO's -25.1% | |
| Efficiency (ROA) | 14.7% ROA vs TAP's -8.9%, ROIC 9.6% vs -10.1% |
STZ vs DEO vs BUD vs TAP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
STZ vs DEO vs BUD vs TAP — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TAP leads in 1 of 6 categories
BUD leads 1 • DEO leads 1 • STZ leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — DEO and TAP each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BUD is the larger business by revenue, generating $119.8B annually — 12.8x STZ's $9.4B. DEO is the more profitable business, keeping 14.7% of every revenue dollar as net income compared to TAP's -18.9%. On growth, TAP holds the edge at +2.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $9.4B | $37.4B | $119.8B | $11.2B |
| EBITDAEarnings before interest/tax | $3.7B | $11.6B | $38.8B | -$1.5B |
| Net IncomeAfter-tax profit | $1.1B | $5.5B | $12.6B | -$2.1B |
| Free Cash FlowCash after capex | $1.8B | $7.7B | $32.2B | $1.2B |
| Gross MarginGross profit ÷ Revenue | +52.0% | +60.0% | +55.2% | +37.8% |
| Operating MarginEBIT ÷ Revenue | +34.5% | +27.9% | +31.7% | -20.3% |
| Net MarginNet income ÷ Revenue | +11.8% | +14.7% | +10.5% | -18.9% |
| FCF MarginFCF ÷ Revenue | +18.8% | +20.6% | +26.9% | +10.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.8% | -29.1% | +0.4% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -15.0% | -24.1% | +32.3% | +35.6% |
Valuation Metrics
TAP leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 19.7x trailing earnings, DEO trades at a 30% valuation discount to BUD's 28.1x P/E. On an enterprise value basis, STZ's 9.4x EV/EBITDA is more attractive than DEO's 11.3x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $26.1B | $46.4B | $138.1B | $8.1B |
| Enterprise ValueMkt cap + debt − cash | $38.1B | $68.6B | $199.1B | $13.5B |
| Trailing P/EPrice ÷ TTM EPS | -333.89x | 19.68x | 28.06x | -3.98x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.70x | 17.82x | 18.81x | 9.17x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.64x | — | — |
| EV / EBITDAEnterprise value multiple | 9.37x | 11.33x | 9.47x | — |
| Price / SalesMarket cap ÷ Revenue | 2.55x | 2.29x | 2.31x | 0.73x |
| Price / BookPrice ÷ Book value/share | 3.82x | 3.53x | 1.85x | 0.80x |
| Price / FCFMarket cap ÷ FCF | 13.44x | 17.27x | 12.34x | 7.58x |
Profitability & Efficiency
Evenly matched — DEO and TAP each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
DEO delivers a 54.0% return on equity — every $100 of shareholder capital generates $54 in annual profit, vs $-19 for TAP. TAP carries lower financial leverage with a 0.60x debt-to-equity ratio, signaling a more conservative balance sheet compared to DEO's 1.85x. On the Piotroski fundamental quality scale (0–9), BUD scores 9/9 vs TAP's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +13.9% | +54.0% | +13.8% | -18.6% |
| ROA (TTM)Return on assets | +5.1% | +14.7% | +6.0% | -8.9% |
| ROICReturn on invested capital | +13.0% | +9.6% | +7.5% | -10.1% |
| ROCEReturn on capital employed | +18.0% | +11.7% | +8.7% | -11.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 9 | 4 |
| Debt / EquityFinancial leverage | 1.70x | 1.85x | 0.81x | 0.60x |
| Net DebtTotal debt minus cash | $12.0B | $22.2B | $61.0B | $5.4B |
| Cash & Equiv.Liquid assets | $68M | $2.2B | $11.2B | $897M |
| Total DebtShort + long-term debt | $12.1B | $24.4B | $72.2B | $6.3B |
| Interest CoverageEBIT ÷ Interest expense | 5.47x | 5.71x | 2.53x | -9.99x |
Total Returns (Dividends Reinvested)
BUD leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BUD five years ago would be worth $11,236 today (with dividends reinvested), compared to $5,612 for DEO. Over the past 12 months, BUD leads with a +24.5% total return vs DEO's -25.1%. The 3-year compound annual growth rate (CAGR) favors BUD at 8.4% vs DEO's -20.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +7.9% | -3.3% | +26.0% | -8.0% |
| 1-Year ReturnPast 12 months | -18.7% | -25.1% | +24.5% | -20.8% |
| 3-Year ReturnCumulative with dividends | -29.0% | -49.3% | +27.5% | -24.8% |
| 5-Year ReturnCumulative with dividends | -30.1% | -43.9% | +12.4% | -14.1% |
| 10-Year ReturnCumulative with dividends | +12.6% | +10.0% | -24.5% | -41.4% |
| CAGR (3Y)Annualised 3-year return | -10.8% | -20.3% | +8.4% | -9.1% |
Risk & Volatility
Evenly matched — BUD and TAP each lead in 1 of 2 comparable metrics.
Risk & Volatility
TAP is the less volatile stock with a -0.01 beta — it tends to amplify market swings less than DEO's 0.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BUD currently trades 96.8% from its 52-week high vs DEO's 71.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.26x | 0.37x | 0.28x | -0.01x |
| 52-Week HighHighest price in past year | $196.91 | $116.69 | $82.91 | $57.57 |
| 52-Week LowLowest price in past year | $126.45 | $72.46 | $56.97 | $40.64 |
| % of 52W HighCurrent price vs 52-week peak | +76.3% | +71.5% | +96.8% | +74.9% |
| RSI (14)Momentum oscillator 0–100 | 45.9 | 63.5 | 70.7 | 47.2 |
| Avg Volume (50D)Average daily shares traded | 1.8M | 1.8M | 2.0M | 2.9M |
Analyst Outlook
DEO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: STZ as "Buy", DEO as "Hold", BUD as "Buy", TAP as "Hold". Consensus price targets imply 48.6% upside for DEO (target: $124) vs 10.9% for BUD (target: $89). For income investors, DEO offers the higher dividend yield at 4.95% vs BUD's 1.63%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $175.70 | $124.00 | $89.00 | $48.30 |
| # AnalystsCovering analysts | 46 | 35 | 45 | 37 |
| Dividend YieldAnnual dividend ÷ price | +2.7% | +4.9% | +1.6% | +4.5% |
| Dividend StreakConsecutive years of raises | 4 | 12 | 0 | 5 |
| Dividend / ShareAnnual DPS | $4.03 | $4.13 | $1.31 | $1.92 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.3% | 0.0% | +0.7% | +8.0% |
TAP leads in 1 of 6 categories (Valuation Metrics). BUD leads in 1 (Total Returns). 3 tied.
STZ vs DEO vs BUD vs TAP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is STZ or DEO or BUD or TAP a better buy right now?
For growth investors, Constellation Brands, Inc.
(STZ) is the stronger pick with 2. 5% revenue growth year-over-year, versus -4. 2% for Molson Coors Beverage Company (TAP). Diageo plc (DEO) offers the better valuation at 19. 7x trailing P/E (17. 8x forward), making it the more compelling value choice. Analysts rate Constellation Brands, Inc. (STZ) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — STZ or DEO or BUD or TAP?
On trailing P/E, Diageo plc (DEO) is the cheapest at 19.
7x versus Anheuser-Busch InBev SA/NV at 28. 1x. On forward P/E, Molson Coors Beverage Company is actually cheaper at 9. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — STZ or DEO or BUD or TAP?
Over the past 5 years, Anheuser-Busch InBev SA/NV (BUD) delivered a total return of +12.
4%, compared to -43. 9% for Diageo plc (DEO). Over 10 years, the gap is even starker: STZ returned +12. 6% versus TAP's -41. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — STZ or DEO or BUD or TAP?
By beta (market sensitivity over 5 years), Molson Coors Beverage Company (TAP) is the lower-risk stock at -0.
01β versus Diageo plc's 0. 37β — meaning DEO is approximately -3130% more volatile than TAP relative to the S&P 500. On balance sheet safety, Molson Coors Beverage Company (TAP) carries a lower debt/equity ratio of 60% versus 185% for Diageo plc — giving it more financial flexibility in a downturn.
05Which is growing faster — STZ or DEO or BUD or TAP?
By revenue growth (latest reported year), Constellation Brands, Inc.
(STZ) is pulling ahead at 2. 5% versus -4. 2% for Molson Coors Beverage Company (TAP). On earnings-per-share growth, the picture is similar: Anheuser-Busch InBev SA/NV grew EPS 10. 0% year-over-year, compared to -302. 8% for Molson Coors Beverage Company. Over a 3-year CAGR, DEO leads at 9. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — STZ or DEO or BUD or TAP?
Diageo plc (DEO) is the more profitable company, earning 11.
6% net margin versus -19. 2% for Molson Coors Beverage Company — meaning it keeps 11. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: STZ leads at 35. 5% versus -21. 0% for TAP. At the gross margin level — before operating expenses — DEO leads at 60. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is STZ or DEO or BUD or TAP more undervalued right now?
On forward earnings alone, Molson Coors Beverage Company (TAP) trades at 9.
2x forward P/E versus 18. 8x for Anheuser-Busch InBev SA/NV — 9. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DEO: 48. 6% to $124. 00.
08Which pays a better dividend — STZ or DEO or BUD or TAP?
All stocks in this comparison pay dividends.
Diageo plc (DEO) offers the highest yield at 4. 9%, versus 1. 6% for Anheuser-Busch InBev SA/NV (BUD).
09Is STZ or DEO or BUD or TAP better for a retirement portfolio?
For long-horizon retirement investors, Molson Coors Beverage Company (TAP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
01), 4. 5% yield). Both have compounded well over 10 years (TAP: -41. 4%, DEO: +10. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between STZ and DEO and BUD and TAP?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: STZ is a mid-cap quality compounder stock; DEO is a mid-cap income-oriented stock; BUD is a mid-cap quality compounder stock; TAP is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.